Multimodality Therapy for N2 Non-Small Cell Lung Cancer: An Evolving Paradigm.

[1]  Steven H. Lin,et al.  Concurrent Versus Sequential Chemoradiation Therapy in Completely Resected Pathologic N2 Non-Small Cell Lung Cancer: Propensity-Matched Analysis of the National Cancer Data Base , 2018, Annals of Surgical Oncology.

[2]  Tarek Mekhail,et al.  Durvalumab after Chemoradiotherapy in Stage III Non–Small‐Cell Lung Cancer , 2017, The New England journal of medicine.

[3]  C. Dooms,et al.  Outcome after PORT in ypN2 or R1/R2 versus no PORT in ypN0 Stage III‐N2 NSCLC after Induction Chemotherapy and Resection , 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[4]  Yinglan Chen,et al.  Neoadjuvant Chemoradiotherapy vesus Chemotherapy alone Followed by Surgery for Resectable Stage III Non-Small-Cell Lung Cancer: a Meta-Analysis , 2016, Scientific Reports.

[5]  W. Curran,et al.  Institutional Enrollment and Survival Among NSCLC Patients Receiving Chemoradiation: NRG Oncology Radiation Therapy Oncology Group (RTOG) 0617. , 2016, Journal of the National Cancer Institute.

[6]  David R. Jones,et al.  Management of stage IIIA (N2) non-small cell lung cancer: A transatlantic perspective. , 2016, The Journal of thoracic and cardiovascular surgery.

[7]  M. Berry,et al.  Adding radiation to induction chemotherapy does not improve survival of patients with operable clinical N2 non-small cell lung cancer. , 2015, The Journal of thoracic and cardiovascular surgery.

[8]  R. Mirimanoff,et al.  Induction chemoradiation in stage IIIA/N2 non-small-cell lung cancer: a phase 3 randomised trial , 2015, The Lancet.

[9]  Y. Nishimura,et al.  A phase 3 study of induction treatment with concurrent chemoradiotherapy versus chemotherapy before surgery in patients with pathologically confirmed N2 stage IIIA nonsmall cell lung cancer (WJTOG9903) , 2012, Cancer.

[10]  V. Rusch,et al.  Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial , 2009, The Lancet.

[11]  N. Willich,et al.  Effect of preoperative chemoradiation in addition to preoperative chemotherapy: a randomised trial in stage III non-small-cell lung cancer. , 2008, The Lancet. Oncology.

[12]  G. Giaccone,et al.  Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer. , 2007, Journal of the National Cancer Institute.

[13]  Y. Ohno,et al.  Results of surgical intervention for p-stage IIIA (N2) non-small cell lung cancer: acceptable prognosis predicted by complete resection in patients with single N2 disease with primary tumor in the upper lobe. , 2004, The Journal of thoracic and cardiovascular surgery.

[14]  H. Kato,et al.  A randomized trial comparing induction chemotherapy followed by surgery with surgery alone for patients with stage IIIA N2 non-small cell lung cancer (JCOG 9209). , 2003, The Journal of thoracic and cardiovascular surgery.

[15]  M. Tsuboi,et al.  Completely resected stage IIIA non-small cell lung cancer: the significance of primary tumor location and N2 station. , 2001, The Journal of thoracic and cardiovascular surgery.

[16]  J. Pignon,et al.  Survival of patients with resected N2 non-small-cell lung cancer: evidence for a subclassification and implications. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  K. Nackaerts,et al.  Survival and prognostic factors in resected N2 non-small cell lung cancer: A study of 140 cases , 1997 .

[18]  R. Stephens,et al.  The role of post-operative radiotherapy in non-small-cell lung cancer: a multicentre randomised trial in patients with pathologically staged T1-2, N1-2, M0 disease. Medical Research Council Lung Cancer Working Party. , 1996, British Journal of Cancer.

[19]  C. Mountain.  Surgery for stage IIIa‐N2 non‐small cell lung cancer , 1994, Cancer.

[20]  J. Roth,et al.  A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer. , 1994, Journal of the National Cancer Institute.

[21]  J. Mate,et al.  A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer. , 1994, The New England journal of medicine.

[22]  N. Martini,et al.  The role of surgery in N2 lung cancer. , 1987, The Surgical clinics of North America.

[23]  P. Goldstraw,et al.  Surgical management of non-small-cell lung cancer with ipsilateral mediastinal node metastasis (N2 disease). , 1994, The Journal of thoracic and cardiovascular surgery.